Understanding glycaemic control and current approaches for screening antidiabetic natural products from evidence-based medicinal plants

作者: Chintha Lankatillake , Tien Huynh , Daniel A. Dias

DOI: 10.1186/S13007-019-0487-8

关键词:

摘要: Type 2 Diabetes Mellitus has reached epidemic proportions as a result of over-nutrition and increasingly sedentary lifestyles. Current therapies, although effective, are not without limitations. These limitations, the alarming increase in prevalence diabetes, soaring cost managing diabetes its complications underscores an urgent need for safer, more efficient affordable alternative treatments. Over 1200 plant species reported ethnomedicine treating these represents important promising source identification novel antidiabetic compounds. Evaluating medicinal plants desirable bioactivity goes hand-in-hand with methods analytical biochemistry separating identifying lead This review aims to provide comprehensive summary current used research form useful resource researchers beginning field. The summarises understanding blood glucose regulation general mechanisms action medications, combines knowledge on common experimental approaches screening extracts activity currently available technologies separation bioactive natural products. Common vivo animal models, vitro silico biochemical assays testing effects discussed particular emphasis such cell-based bioassays insulin secretagogues insulinomimetics. Enzyme inhibition molecular docking also highlighted. role metabolomics, metabolite profiling, dereplication data high-throughput discovery agents is reviewed. Finally, this sample preparation techniques liquid–liquid extraction, solid phase supercritical fluid critical function nuclear magnetic resonance high resolution liquid chromatography–mass spectrometry dereplication, putative structure elucidation compounds from evidence-based plants.

参考文章(279)
Masa Skelin, Marjan Rupnik, Avrelija Cencič, None, Pancreatic beta cell lines and their applications in diabetes mellitus research ALTEX-Alternatives to Animal Experimentation. ,vol. 27, pp. 105- 113 ,(2010) , 10.14573/ALTEX.2010.2.105
Gisela Wilcox, Insulin and Insulin Resistance The Clinical biochemist. Reviews / Australian Association of Clinical Biochemists. ,vol. 26, pp. 19- 39 ,(2005)
H Bischoff, Pharmacology of alpha-glucosidase inhibition. European Journal of Clinical Investigation. pp. 3- 10 ,(1994)
F G Banting, W R Campbell, C H Best, A A Fletcher, J B Collip, Pancreatic Extracts in the Treatment of Diabetes Mellitus. Canadian Medical Association Journal. ,vol. 12, pp. 141- 146 ,(1922)
Konstantinos Laios, Marianna Karamanou, Zenia Saridaki, George Androutsos, Aretaeus of Cappadocia and the first description of diabetes. Hormones (Greece). ,vol. 11, pp. 109- 113 ,(2012) , 10.1007/BF03401545
Nicholas A. Delamere, Ascorbic acid and the eye. Sub-cellular biochemistry. ,vol. 25, pp. 313- 329 ,(1996) , 10.1007/978-1-4613-0325-1_16
Mohamed A. Farag, Andrea Porzel, Ludger A. Wessjohann, Unraveling the active hypoglycemic agent trigonelline in Balanites aegyptiaca date fruit using metabolite fingerprinting by NMR Journal of Pharmaceutical and Biomedical Analysis. ,vol. 115, pp. 383- 387 ,(2015) , 10.1016/J.JPBA.2015.08.003
Atanas G. Atanasov, Birgit Waltenberger, Eva-Maria Pferschy-Wenzig, Thomas Linder, Christoph Wawrosch, Pavel Uhrin, Veronika Temml, Limei Wang, Stefan Schwaiger, Elke H. Heiss, Judith M. Rollinger, Daniela Schuster, Johannes M. Breuss, Valery Bochkov, Marko D. Mihovilovic, Brigitte Kopp, Rudolf Bauer, Verena M. Dirsch, Hermann Stuppner, Discovery and resupply of pharmacologically active plant-derived natural products: A review Biotechnology Advances. ,vol. 33, pp. 1582- 1614 ,(2015) , 10.1016/J.BIOTECHADV.2015.08.001
Aileen JF King, The use of animal models in diabetes research British Journal of Pharmacology. ,vol. 166, pp. 877- 894 ,(2012) , 10.1111/J.1476-5381.2012.01911.X